To effectively battle cancer, scientists must study the battlefield. Now, in a recent study published in Nature ...

Switching from nanofibres in the blood to virus-like particles in a tumour environment brings drugs to where they are needed ...

A recent study published in Engineering delves into the advancements in wound management, specifically focusing on ...

Researchers found that the Wnt5a protein, secreted by inflammatory fibroblasts within cancerous tumors, inhibits angiogenesis and consequently promotes hypoxia within tumors. Hypoxic conditions help ...

A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation ...

What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...

Individuals with both sickle cell disease (SCD) and sickle cell trait are at higher risk than others of developing renal medullary cancer (RMC), the rarest and deadliest subtype of kidney cancer.

And yet, in high altitudes on the Tibetan Plateau, where oxygen levels in the air people breathe are notably lower than lower ...

New research reveals how elevated eye pressure distorts blood vessels and disrupts oxygen delivery, potentially accelerating ...

Cardiac regenerative medicine represents a promising strategy aimed at restoring impaired heart function by replacing or ...

Ai Mediq SA today officially launched Intermittent Hypoxia-Hyperoxia Therapy (IHHT), a science-backed, non-invasive breathing ...